Cite

    Yamamura, J., Kamigaki, S., Tsujie, M., Fujita, J., Osato, H., Higashi, C., Kanaizumi, H., Tanaka, Y., Hamada, M., Shinzaki, W., Hasimoto, Y., & Komoike, Y. (n.d.). 342PResponse to primary treatment for first recurrence independently influences survival of patients with hormone receptor-positive, HER2-negative breast cancer: A multicenter study of 236 recurrent metastatic patients. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095515506.0x00003c